News

Biolidics calls for trade halt pending reimbursements for cancer tests

The fees related to the tests will be reimbursed by China’s National Healthcare Security Administration under its national basic medical insurance programme.

Biolidics calls for trade halt pending reimbursements for cancer tests

The fees related to the tests will be reimbursed by China’s National Healthcare Security Administration under its national basic medical insurance programme.

Novena Global Lifecare to set up $150m Sino-Singapore healthcare fund

It will invest in medical services, biomedical projects, mature drugs and precision medicine companies.

Thomson Medical Group sets up $500m multicurrency debt issuance programme

The net proceeds will finance its borrowings, expansions and capital expenditure.

Migrant workers gain access to universal healthcare in Thailand

An estimated 1.5 million undocumented migrants registered with the Ministry of Public Health in 2018.

Metro Pacific gears for $2b hospital sale

The conglomerate plans to start the sale process in July.

Hong Kong medical costs up 9.3% in 2018

The situation isn't any easier for Singapore where costs grew 10%.

Public hospitals in Singapore snapped up three-fourths of tertiary admissions in 2006-2018

Private players were left to fight over the remaining 22-23% of the market.

Singapore's healthcare expenditure to hit US$24.6b by 2020

Public healthcare allowances are tipped to grow at a 8.3% CAGR  between 2016-2020.

How much are Singaporeans covered by public health insurance?

Nearly 7 in 10 are already covered by the Integrated Shield plan in 2017.

Hong Kong-based Zuellig Pharma buys Singapore healthcare startup Klinify

Klinify is being used by 800 doctors in Malaysia to manage their clinics.

Malaysia hospital developments could uplift IHH earnings

It is also beginning to reap better contributions from Fortis.

Clearbridge Health expands Hong Kong presence with 1,500 sqft clinic

The new clinic features a dedicated space to hold educational health talks for medical tourist agents and patients.

Government reforms to boost China's pharmaceutical sector: report

The sector is described to be “one of the most attractive investment destinations in the Asia Pacific region”.